ABSTRACT
Objective To investigate the expression profiles and chromosome distribution characteristics of miRNA in bone marrow samples between the patients with adult B-cell acute lymphoblastic leukemia (B-ALL) and their controls. Methods Illumina sequencing technology was applied to perform global miRNA expression analysis and chromosome distribution analysis in the bone marrow samples of 15 adult B-ALL patients relative to a control group of 10 patients without hematologic malignancies. Then, qPCR was carried out to validate the reliability of the se-quencing data. Results In total,291 differentially expressed miRNAs including 168 up-regulated and 123 down-regulated miRNAs were indentified in adult B-ALL patients as compared with their controls. Despite the distribution of miRNA genes in chromosome was similar in both samples, the distribution of miRNA expression abundance in chromosome show obvious differences. B-ALL group was mainly located in the chromosome 1, 2, 5 and 9, while the control group was mainly located in the chromosome 3,7,9,17 and X. Conclusions The altered expression profile of miRNA in bone marrow samples of adult B-ALL patients implies that aberrantly expressed miRNAs maybe plays roles in the occurrence and development of B-ALL.
ABSTRACT
Objective To investigate the expression profiles and chromosome distribution characteristics of miRNA in bone marrow samples between the patients with adult B-cell acute lymphoblastic leukemia (B-ALL) and their controls. Methods Illumina sequencing technology was applied to perform global miRNA expression analysis and chromosome distribution analysis in the bone marrow samples of 15 adult B-ALL patients relative to a control group of 10 patients without hematologic malignancies. Then, qPCR was carried out to validate the reliability of the se-quencing data. Results In total,291 differentially expressed miRNAs including 168 up-regulated and 123 down-regulated miRNAs were indentified in adult B-ALL patients as compared with their controls. Despite the distribution of miRNA genes in chromosome was similar in both samples, the distribution of miRNA expression abundance in chromosome show obvious differences. B-ALL group was mainly located in the chromosome 1, 2, 5 and 9, while the control group was mainly located in the chromosome 3,7,9,17 and X. Conclusions The altered expression profile of miRNA in bone marrow samples of adult B-ALL patients implies that aberrantly expressed miRNAs maybe plays roles in the occurrence and development of B-ALL.
ABSTRACT
The protective effects of puerarin on liver damage were evaluated by carbon tetrachloride (CCl4)-induced hepatotoxicity in rats. Male rats were orally treated with puerarin daily, and received CCl4 intraperitoneally twice a week for 4 weeks. Our results showed that puerarin at doses of 50, 100, and 200 mg/kg b. w. significantly reduced the elevated activities of serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and lactate dehydrogenase at least 15%, 17%, 14% and 18%, respectively. In addition, puerarin at different doses significantly decreased (p<0.05) the level of hepatic thiobarbituric acid reactive substances compared to the CCl4-treated group. Furthermore, the treatment of puerarin was also found to significantly increase the activities of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, and glutathione content at least 40%, 12%, 25%, 52%, 17% and 44% in the liver of CCl4-treated rats, respectively. Liver histopathology also showed that puerarin reduced the incidence of liver lesions induced by CCl4. The results suggest that puerarin exhibits potent hepatoprotective effects on CCl4-induced liver damages in rats, and that the hepatoprotective effects of puerarin may be due to both the inhibition of lipid peroxidation and to increase of antioxidant enzymes activity.